Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene

被引:12
|
作者
Liang, HL [1 ]
Lunec, J [1 ]
机构
[1] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
MDM2; p53; promoter;
D O I
10.1016/j.gene.2005.07.018
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The MDM2 oncogene exhibits a complex expression pattern partly due to the usage of multiple promoters. Two MDM2 promoters (PI and P2) have been identified. P1 is located upstream of exon 1 and is modulated by PTEN. P2 sits in intron 1 and is activated by p53. Here we report the discovery of a third promoter (designated P3) in intron 3 of this gene, which contains a TATA-box element and p53DNA-binding sequences. DNA-protein binding assays indicated that p53 bound to this region specifically. This region also demonstrated promoter activity in a reporter gene system, which was down-regulated by p53. Furthermore, experiments combining P2 and P3 in the same reporter construct indicated that P3 had a suppressive effect on P2 at high levels of p53. These results suggest that one of the P3 functions is to dampen the expression of MDM2 at high levels of p53, adding an additional element to the feedback loop between p53 and MDM2. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 50 条
  • [1] A novel p53 binding sequence in intron 3 of the human MDM2 proto-oncogene:: A putative additional p53-dependent promoter
    Liang, H
    Lunec, J
    BRITISH JOURNAL OF CANCER, 1998, 78 : 18 - 18
  • [2] THE 2ND INTRON OF THE HUMAN GALECTIN-3 GENE HAS A STRONG PROMOTER ACTIVITY DOWN-REGULATED BY P53
    RAIMOND, J
    ROULEUX, F
    MONSIGNY, M
    LEGRAND, A
    FEBS LETTERS, 1995, 363 (1-2) : 165 - 169
  • [3] Functional interaction of a TRRAP histone acetyltransferase complex with p53 at the promoter of the mdm2 oncogene
    Chatterjee, C
    Ard, P
    Kunjibettu, S
    Gralinski, L
    Aside, L
    Weaver, VM
    McMahon, SB
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 246A - 246A
  • [4] The Effect of p53 Mutations on Binding to the Mdm2 Promoter
    Morin-Gaona, Cassandra
    Nogaj, Luiza
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S654 - S654
  • [5] p53 inhibition by MDM2 in human pterygium
    Cao, Di
    Tsz Kin Ng
    Yip, Yolanda W. Y.
    Young, Alvin L.
    Pang, Chi Pui
    Chu, Wai Kit
    Jhanji, Vishal
    EXPERIMENTAL EYE RESEARCH, 2018, 175 : 142 - 147
  • [6] P53 degradation by Mdm2 - A novel mechanism for regulation of p53 stability
    Nampoothiri, VK
    CURRENT SCIENCE, 1998, 75 (09): : 875 - 877
  • [7] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [8] MDM2与p53
    金晶
    刘耕陶
    癌症, 2001, (06) : 663 - 666
  • [9] Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation
    Kulikov, Roman
    Winter, Markus
    Blattner, Christine
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (39) : 28575 - 28583
  • [10] Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
    Costa, Barbara
    Bendinelli, Sara
    Gabelloni, Pamela
    Da Pozzo, Eleonora
    Daniele, Simona
    Scatena, Fabrizio
    Vanacore, Renato
    Campiglia, Pietro
    Bertamino, Alessia
    Gomez-Monterrey, Isabel
    Sorriento, Daniela
    Del Giudice, Carmine
    Iaccarino, Guido
    Novellino, Ettore
    Martini, Claudia
    PLOS ONE, 2013, 8 (08):